Copyright Reports & Markets. All rights reserved.

Global Allergy Immunotherapies Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Allergy Immunotherapies by Type
    • 1.3.1 Overview: Global Allergy Immunotherapies Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Allergy Immunotherapies Consumption Value Market Share by Type in 2024
    • 1.3.3 Subcutaneous Immunotherapy
    • 1.3.4 Sublingual Immunotherapy
  • 1.4 Global Allergy Immunotherapies Market by Application
    • 1.4.1 Overview: Global Allergy Immunotherapies Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Allergic Rhinitis
    • 1.4.3 Allergic Asthma
    • 1.4.4 Other
  • 1.5 Global Allergy Immunotherapies Market Size & Forecast
  • 1.6 Global Allergy Immunotherapies Market Size and Forecast by Region
    • 1.6.1 Global Allergy Immunotherapies Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Allergy Immunotherapies Market Size by Region, (2020-2031)
    • 1.6.3 North America Allergy Immunotherapies Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Allergy Immunotherapies Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Allergy Immunotherapies Market Size and Prospect (2020-2031)
    • 1.6.6 South America Allergy Immunotherapies Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Allergy Immunotherapies Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 ALK
    • 2.1.1 ALK Details
    • 2.1.2 ALK Major Business
    • 2.1.3 ALK Allergy Immunotherapies Product and Solutions
    • 2.1.4 ALK Allergy Immunotherapies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 ALK Recent Developments and Future Plans
  • 2.2 Stallergenes
    • 2.2.1 Stallergenes Details
    • 2.2.2 Stallergenes Major Business
    • 2.2.3 Stallergenes Allergy Immunotherapies Product and Solutions
    • 2.2.4 Stallergenes Allergy Immunotherapies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Stallergenes Recent Developments and Future Plans
  • 2.3 HAL
    • 2.3.1 HAL Details
    • 2.3.2 HAL Major Business
    • 2.3.3 HAL Allergy Immunotherapies Product and Solutions
    • 2.3.4 HAL Allergy Immunotherapies Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 HAL Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Allergy Immunotherapies Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Allergy Immunotherapies by Company Revenue
    • 3.2.2 Top 3 Allergy Immunotherapies Players Market Share in 2024
    • 3.2.3 Top 6 Allergy Immunotherapies Players Market Share in 2024
  • 3.3 Allergy Immunotherapies Market: Overall Company Footprint Analysis
    • 3.3.1 Allergy Immunotherapies Market: Region Footprint
    • 3.3.2 Allergy Immunotherapies Market: Company Product Type Footprint
    • 3.3.3 Allergy Immunotherapies Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Allergy Immunotherapies Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Allergy Immunotherapies Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Allergy Immunotherapies Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Allergy Immunotherapies Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Allergy Immunotherapies Consumption Value by Type (2020-2031)
  • 6.2 North America Allergy Immunotherapies Market Size by Application (2020-2031)
  • 6.3 North America Allergy Immunotherapies Market Size by Country
    • 6.3.1 North America Allergy Immunotherapies Consumption Value by Country (2020-2031)
    • 6.3.2 United States Allergy Immunotherapies Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Allergy Immunotherapies Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Allergy Immunotherapies Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Allergy Immunotherapies Consumption Value by Type (2020-2031)
  • 7.2 Europe Allergy Immunotherapies Consumption Value by Application (2020-2031)
  • 7.3 Europe Allergy Immunotherapies Market Size by Country
    • 7.3.1 Europe Allergy Immunotherapies Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Allergy Immunotherapies Market Size and Forecast (2020-2031)
    • 7.3.3 France Allergy Immunotherapies Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Allergy Immunotherapies Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Allergy Immunotherapies Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Allergy Immunotherapies Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Allergy Immunotherapies Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Allergy Immunotherapies Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Allergy Immunotherapies Market Size by Region
    • 8.3.1 Asia-Pacific Allergy Immunotherapies Consumption Value by Region (2020-2031)
    • 8.3.2 China Allergy Immunotherapies Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Allergy Immunotherapies Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Allergy Immunotherapies Market Size and Forecast (2020-2031)
    • 8.3.5 India Allergy Immunotherapies Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Allergy Immunotherapies Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Allergy Immunotherapies Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Allergy Immunotherapies Consumption Value by Type (2020-2031)
  • 9.2 South America Allergy Immunotherapies Consumption Value by Application (2020-2031)
  • 9.3 South America Allergy Immunotherapies Market Size by Country
    • 9.3.1 South America Allergy Immunotherapies Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Allergy Immunotherapies Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Allergy Immunotherapies Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Allergy Immunotherapies Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Allergy Immunotherapies Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Allergy Immunotherapies Market Size by Country
    • 10.3.1 Middle East & Africa Allergy Immunotherapies Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Allergy Immunotherapies Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Allergy Immunotherapies Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Allergy Immunotherapies Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Allergy Immunotherapies Market Drivers
  • 11.2 Allergy Immunotherapies Market Restraints
  • 11.3 Allergy Immunotherapies Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Allergy Immunotherapies Industry Chain
  • 12.2 Allergy Immunotherapies Upstream Analysis
  • 12.3 Allergy Immunotherapies Midstream Analysis
  • 12.4 Allergy Immunotherapies Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Allergy Immunotherapies market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system"s response.

    The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
    In Southeast Asia Allergy Immunotherapies key players include ALK, Stallergenes, etc. Southeast Asia top two manufacturers hold a share about 65%.
    Singapore is the largest market, with a share over 30%, followed by Thailand and Malaysia, both have a share about 35 percent.
    In terms of product, Subcutaneous Immunotherapy is the largest segment, with a share about 43%. And in terms of application, the largest application is Allergic Rhinitis, followed by Allergic Asthma, etc.
    This report is a detailed and comprehensive analysis for global Allergy Immunotherapies market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Allergy Immunotherapies market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Allergy Immunotherapies market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Allergy Immunotherapies market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Allergy Immunotherapies market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Allergy Immunotherapies
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Allergy Immunotherapies market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ALK, Stallergenes, HAL, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Allergy Immunotherapies market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Subcutaneous Immunotherapy
    Sublingual Immunotherapy
    Market segment by Application
    Allergic Rhinitis
    Allergic Asthma
    Other
    Market segment by players, this report covers
    ALK
    Stallergenes
    HAL
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Allergy Immunotherapies product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Allergy Immunotherapies, with revenue, gross margin, and global market share of Allergy Immunotherapies from 2020 to 2025.
    Chapter 3, the Allergy Immunotherapies competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Allergy Immunotherapies market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Allergy Immunotherapies.
    Chapter 13, to describe Allergy Immunotherapies research findings and conclusion.

    Buy now